Tandem Diabetes Care (TNDM)

$113.48 2.30 (2.07%)

16:00 EST TNDM Stock Quote Delayed 30 Minutes

Bret Kenwell

5 Top Stock Trades for Friday: SIG, MSFT, TNDM

By Bret Kenwell, InvestorPlace Contributor Jan 16, 2020

Signet Jewelers, Microsoft, Tandem Diabetes, InMode and Taiwan Semiconductor were our top stock trades for Friday -- and here's why.

8 Stocks to Buy That Are Growing Faster Than Amazon

10 Cheap Stocks to Buy Now

Why Tandem Diabetes Stock Will Rally Much Further

More Articles

Volume:

Previous Close -

Market Cap 7.15B

PE Ratio 263.91

EPS 0.43

Volume (Avg. Vol.) 1.40M

Day's Range $106.49 - $113.99

52-Week Range $76.19 - $155.86

Dividend & Yield N/A (N/A)

TNDM Stock Predictions, Articles, and Tandem Diabetes Care News

From InvestorPlace
From the Web

5 Top Stock Trades for Tuesday: BAC, NFLX, ATVI, INTC

By Bret Kenwell, InvestorPlace Contributor Apr 1, 2019

Tandem Diabetes, Netflix, Activision Blizzard, Intel and Bank of America are our top stock trades to watch going into Tuesday.

Wait for the Inevitable Pullback to Buy TNDM Stock

By Will Healy, InvestorPlace Contributor Feb 28, 2019

TNDM stock should enjoy a bright, long-term future, but the quick run-up could mean Tandem Diabetes Care stock sees a near-term pullback.

5 Healthcare Stocks to Buy for Complete Portfolio Wellness

By Josh Enomoto, InvestorPlace Contributor Oct 10, 2018

Thanks to advancing technologies and a generally positive economy, healthcare stocks are back in the limelight.

Tandem Diabetes Is Firing on All Cylinders

By Chris Lau, InvestorPlace Contributor Sep 11, 2018

Tandem Diabetes sold shares of TNDM stock, but Tandem Diabetes stock continued to rocket higher. TNDM's Q2 results impressed investors, but its seasonally strong Q4 earnings could wow them more.

Why Tandem Stock Could Continue Its Rally

By Chris Lau, InvestorPlace Contributor Jun 25, 2018

Tandem stock rocketed to a new high after the company won an FDA approval and two analyst upgrades. At a one billion dollar market cap, the stock still has upside.

Tandem Diabetes Care Inc Is Up 194% — And It’s Not Done Yet

By Chris Lau, InvestorPlace Contributor Apr 13, 2018

Tandem Diabetes is firing on all cylinders and markets are already noticing. TNDM has more growth ahead than is currently priced into the stock.

4 Top Growth Picks as MedTech Battle Rages On

By Zacks Investment Research Oct 16, 2017

Trump’s Obamacare replacement saga has made growth picks great opportunities for investors in MedTech sector.

Benzinga's Top Ratings Upgrades, Downgrades For January 19, 2022

From Benzinga Jan 19, 2022

Upgrades For Rocket Companies Inc (NYSE:RKT), JP Mo...

46 Biggest Movers From Yesterday

From Benzinga Dec 16, 2021

Gainers Theseus Pharmaceuticals, Inc. (NASDAQ: THRX) gained 34.1% to settle at $12.58 on Wednesday. CMC Materials, Inc. (NASDAQ: CCMP) climbed 33.9% to close at $195.50 on...

Custom Pre-earnings Bullish Diagonal Trigger in Tandem Diabetes Care Inc

From Capital Market Laboratories Oct 29, 2021

Custom Pre-earnings Bullish Diagonal Trigger in Tandem Diabetes Care Inc (NASDAQ:TNDM) Earnings.

12 Health Care Stocks Moving In Wednesday's Intraday Session

From Benzinga Dec 15, 2021

Gainers Biofrontera (NASDAQ:

36 Stocks Moving In Wednesday's Mid-Day Session

From Benzinga Dec 15, 2021

Gainers Nxt-ID, Inc. (NASDAQ: NXTD) shares gained 28.9% to $3.21 after the company said it was awarded U.S. General Services Administration contract to distribute personal...

Analysts Offer Insights on Healthcare Companies: ACADIA Pharmaceuticals (ACAD), Nektar Therapeutics (NKTR) and Tandem Diabetes Care (TNDM)

From TipRanks Dec 9, 2021

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on ACADIA Pharmaceuticals (